2001
DOI: 10.1248/bpb.24.701
|View full text |Cite
|
Sign up to set email alerts
|

Inhibitory Effects of Anti-Inflammatory Drugs on Interleukin-6 Bioactivity.

Abstract: Interleukin-6 (IL-6) is a proinflammatory cytokine which is produced by both lymphoid and nonlymphoid cells.1) The receptor for IL-6 is composed of two polypeptide chains called a-subunit and b-subunit.1,2) The a-subunit is the ligand-binding chain with a molecular weight of approximately 80 kDa, and is also known as gp80.2,3) The b-subunit is known as gp130 and is the signal-transducing chain of the receptor complex.2,4) The gp130 is shared by a family of cytokines including oncostatin M (OSM), leukemia inhib… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

4
18
0

Year Published

2002
2002
2024
2024

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 44 publications
(22 citation statements)
references
References 21 publications
(10 reference statements)
4
18
0
Order By: Relevance
“…Based on experimental studies, corticosteroids have been shown to control gene expression of inflammatory mediators. This regulation influences the expression of vascular endothelial growth factor (VEGF), inhibits pro-inflammatory genes such as tumor necrosis factor-alpha (TNF- α ) and other inflammatory chemokines, and induces the expression of anti-inflammatory factors such as pigment-derived growth factor (PEDF) [24]. Additionally, steroids seem to reduce the expression of matrix metalloproteinases (MMPs) and to downregulate intercellular adhesion molecule 1 (ICAM-1) on choroidal endothelial cells [5–11].…”
Section: Introductionmentioning
confidence: 99%
“…Based on experimental studies, corticosteroids have been shown to control gene expression of inflammatory mediators. This regulation influences the expression of vascular endothelial growth factor (VEGF), inhibits pro-inflammatory genes such as tumor necrosis factor-alpha (TNF- α ) and other inflammatory chemokines, and induces the expression of anti-inflammatory factors such as pigment-derived growth factor (PEDF) [24]. Additionally, steroids seem to reduce the expression of matrix metalloproteinases (MMPs) and to downregulate intercellular adhesion molecule 1 (ICAM-1) on choroidal endothelial cells [5–11].…”
Section: Introductionmentioning
confidence: 99%
“…IL-6 is a multifunctional cytokine acting in various cells. It induces the differentiation of β cells to antibody-producing plasma cells, T cell growth and differentiation, the differentiation of myeloid leukemic cell lines into macrophages, megakaryocyte maturation, and the neuronal differentiation of PC12 cells development (25,26). BUD is reported to exhibit anti-inflammatory activity via the inhibition of inflammatory mediators TNF-α and IL-6.…”
Section: Introductionmentioning
confidence: 99%
“…During this rapid changing phase of IL-6 expression after injury, each treatment's peak action on IL-6 expression would be affected by several factors, such as the concentration of maximal inhibition of IL-6, 25,26 time for peak effect on IL-6, 21,27 their mean time concentration in cornea, 28,29 rate of accumulation in the cornea 30 and each drug's intrinsic inhibitory effect on IL-6 cytokine. 25 Second, IL-6 is pleiotrophic and also has dual actions, proinflammtory and antiinflammtory. 21,[31][32][33][34] The high expression of IL-6 in the treatment group can be interpreted as antiinflammatory (immunomodualting) action of IL-6.…”
Section: Discussionmentioning
confidence: 99%